AbbVie says that Elahere is the first and only folate receptor alpha (FRɑ)-directed antibody drug conjugate (ADC) medicine ...

Shares of Aldeyra Therapeutics gained after the Food and Drug Administration accepted the company's resubmitted new drug application for its treatment of dry eye disease for review. The stock rose 11% ...

ALDX announced that the FDA has accepted its resubmitted new drug application (NDA) for reproxalap, a first-in-class ...

With the expansion of their agreement, AbbVie has agreed to pay Aldeyra $100 million upfront; Aldeyra is also eligible to ...

Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...

He also held senior positions at NeoPharm Inc., and Abbott (now AbbVie), where he led the global development ... Mr. Walbert is also actively involved in the Economic Club of Chicago, the Commercial ...

The installed renewable energy capacity (including large hydro) in India is projected to reach 250 GW by March 2026, from the ...

Nvidia reports earnings after the bell on Wednesday. The focus will be on how quickly it can ramp up Blackwell sales in the ...

Newark once again was the top most documented office location, with 21 in total, followed by Princeton, with 13, and Roseland ...

Bitcoin-focused exchange-traded funds (ETFs) have reached a new milestone, with total assets under management for crypto ...

Johnson & Johnson (NYSE:JNJ) announced today more than 90 abstracts featuring data from the Company's differentiated blood cancer portfolio and pipeline will be presented at the 66th American Society ...

Among participants in the landmark ORAL Surveillance study assigned to the JAK inhibitor tofacitinib (Xeljanz) and also using ...